Welcome to LookChem.com Sign In|Join Free

CAS

  • or
Silane, (1,1-dimethylethyl)dimethyl[(1-phenyl-3-butenyl)oxy]- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

340165-30-2 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 340165-30-2 Structure
  • Basic information

    1. Product Name: Silane, (1,1-dimethylethyl)dimethyl[(1-phenyl-3-butenyl)oxy]-
    2. Synonyms:
    3. CAS NO:340165-30-2
    4. Molecular Formula: C16H26OSi
    5. Molecular Weight: 262.467
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 340165-30-2.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: N/A
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: Silane, (1,1-dimethylethyl)dimethyl[(1-phenyl-3-butenyl)oxy]-(CAS DataBase Reference)
    10. NIST Chemistry Reference: Silane, (1,1-dimethylethyl)dimethyl[(1-phenyl-3-butenyl)oxy]-(340165-30-2)
    11. EPA Substance Registry System: Silane, (1,1-dimethylethyl)dimethyl[(1-phenyl-3-butenyl)oxy]-(340165-30-2)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 340165-30-2(Hazardous Substances Data)

340165-30-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 340165-30-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,4,0,1,6 and 5 respectively; the second part has 2 digits, 3 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 340165-30:
(8*3)+(7*4)+(6*0)+(5*1)+(4*6)+(3*5)+(2*3)+(1*0)=102
102 % 10 = 2
So 340165-30-2 is a valid CAS Registry Number.

340165-30-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name tert-butyl-dimethyl-(1-phenylbut-3-enoxy)silane

1.2 Other means of identification

Product number -
Other names 1-tert-butyldimethylsilyloxy-1-phenylbut-3-ene

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:340165-30-2 SDS

340165-30-2Relevant articles and documents

Structure-Activity Studies of Truncated Latrunculin Analogues with Antimalarial Activity

Varghese, Swapna,Rahmani, Rapha?l,Drew, Damien R.,Beeson, James G.,Baum, Jake,Smith, Brian J.,Baell, Jonathan B.

, p. 679 - 693 (2020/11/30)

Malarial parasites employ actin dynamics for motility, and any disruption to these dynamics renders the parasites unable to effectively establish infection. Therefore, actin presents a potential target for malarial drug discovery, and naturally occurring actin inhibitors such as latrunculins are a promising starting point. However, the limited availability of the natural product and the laborious route for synthesis of latrunculins have hindered their potential development as drug candidates. In this regard, we recently described novel truncated latrunculins, with superior actin binding potency and selectivity towards P. falciparum actin than the canonical latrunculin B. In this paper, we further explore the truncated latrunculin core to summarize the SAR for inhibition of malaria motility. This study helps further understand the binding pattern of these analogues in order to develop them as drug candidates for malaria.

BICYCLIC KETONE COMPOUNDS AND METHODS OF USE THEREOF

-

Page/Page column 53; 54, (2019/02/02)

The invention provides novel compounds having the general formula (I): (I) wherein R1, the A ring and the B ring are as described herein, pharmaceutical compositions including the compounds, and methods of using the compounds.

BICYCLIC COMPOUNDS FOR USE AS RIP1 KINASE INHIBITORS

-

Page/Page column 43, (2019/05/07)

The invention provides novel compounds having the general formula (I) or pharmaceutically acceptable salts thereof, wherein RA, RB1, RB2, the A ring and the B ring are as described herein, pharmaceutical compositions inclu

N-[4-OXO-2,3-DIHYDRO-1,5-BENZOXAZEPIN-3-YL]-5,6-DIHYDRO-4H-PYRROLO[1,2-B]PYRAZOL E-2-CARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS AS RIP1 KINASE INHIBITORS FOR TREATING E.G. IRRITABLE BOWEL SYNDROME (IBS)

-

Page/Page column 37; 41, (2019/11/12)

The invention provides compounds having the general formula (I): or pharmaceutically acceptable salts thereof, wherein X, Y, R1, R2, R7a, R7b, X, RB1, RB2, n, p, q, the A ring and the B ring are as described herein, pharmaceutical compositions including the compounds, and the compounds for use as receptor-interacting protein-1 (RIP1) kinase inhibitors in methods of treating e.g. Parkinson's or Alzheimer's disease, irritable bowel disorders (IBD), Crohn's disease, respiratory distress syndrome (ARDS) or chronic obstructive pulmonary disease (COPD). An exemplary compound is e.g. (4S,6S)-4-fluoro-6-phenyl-N-[(3S)-5-methyl-4-oxo-2,3-dihydro-l,5- benzoxazepin-3-yl]-5,6-dihydro-4H-pyrrolo[l,2-b]pyrazole-2- carboxamide (example 11) with a Ki (uM) in a RIP1 assay of 0.0044 uM..

Z -selective alkene isomerization by high-spin cobalt(II) complexes

Chen, Chi,Dugan, Thomas R.,Brennessel, William W.,Weix, Daniel J.,Holland, Patrick L.

supporting information, p. 945 - 955 (2014/02/14)

The isomerization of simple terminal alkenes to internal isomers with Z-stereochemistry is rare, because the more stable E-isomers are typically formed. We show here that cobalt(II) catalysts supported by bulky β-diketiminate ligands have the appropriate kinetic selectivity to catalyze the isomerization of some simple 1-alkenes specifically to the 2-alkene as the less stable Z-isomer. The catalysis proceeds via an "alkyl" mechanism, with a three-coordinate cobalt(II) alkyl complex as the resting state. β-Hydride elimination and [1,2]-insertion steps are both rapid, as shown by isotopic labeling experiments. A steric model explains the selectivity through a square-planar geometry at cobalt(II) in the transition state for β-hydride elimination. The catalyst works not only with simple alkenes, but also with homoallyl silanes, ketals, and silyl ethers. Isolation of cobalt(I) or cobalt(II) products from reactions with poor substrates suggests that the key catalyst decomposition pathways are bimolecular, and lowering the catalyst concentration often improves the selectivity. In addition to a potentially useful, selective transformation, these studies provide a mechanistic understanding for catalytic alkene isomerization by high-spin cobalt complexes, and demonstrate the effectiveness of steric bulk in controlling the stereoselectivity of alkene formation.

An approach to aliphatic 1,8-stereocontrol: Diastereoselective syntheses of (±)-patulolide C and (±)-epipatulolide C

Hoegenauer, E. Kate,Thomas, Eric J.

, p. 6995 - 7014,20 (2012/12/12)

The tin(iv) bromide promoted reaction of 7-hydroxy-7-phenylhept-2- enyl(tributyl)stannane 11 with benzaldehyde gave a mixture of the epimeric 1,8-diphenyloct-3-ene-1,8-diols 12 and so indirect methods were developed for aliphatic 1,8-stereocontrol to comp

Mesoporous aluminosilicate-catalyzed allylation of carbonyl compounds and acetals

Ito, Suguru,Hayashi, Akira,Komai, Hirotomo,Yamaguchi, Hitoshi,Kubota, Yoshihiro,Asami, Masatoshi

, p. 2081 - 2089 (2011/04/19)

A mesoporous aluminosilicate (Al-MCM-41) was found to be an effective heterogeneous catalyst for the reaction of both carbonyl compounds and acetals with allylsilanes to afford the corresponding homoallyl silyl ethers and homoallyl alkyl ethers, respectively. Both the mesoporous structure and the presence of aluminum moiety were indispensable for the high catalytic activity of Al-MCM-41. Moreover, Al-MCM-41 could catalyze the reaction of acetals chemoselectively in the presence of the corresponding carbonyl compounds. The solid acid catalyst Al-MCM-41 could be recovered easily by filtration and could be reused three times without a significant loss of catalytic activity.

Expeditious syntheses of (±)-allo-sedamine and (±)-allo- lobeline via a combination of aza-Sakurai-Hosomi and hydroformylation reactions

Spangenberg, Thomas,Airiau, Etienne,Thuong, Mathieu Bui The,Donnard, Morgan,Billet, Manuella,Mann, André

scheme or table, p. 2859 - 2863 (2009/05/07)

The expeditious preparation of allo-sedamine and allo-lobeline via 1,3-diastereoselective aza-Sakurai-Hosomi reaction followed by hydroformylation is reported. Georg Thieme Verlag Stuttgart.

Total synthesis of (+/-)-diospongin A via Prins reaction

Hiebel, Marie-Aude,Pelotier, Béatrice,Piva, Olivier

, p. 7874 - 7878 (2008/02/08)

A straightforward synthesis of (+/-)-diospongin A starting from benzaldehyde is described. A Prins cyclization reaction to control the relative configuration of the three stereogenic centers and a Mitsunobu inversion represent the key steps of the approac

Crucial role of the ligand of silyl Lewis acid in the Mukaiyama aldol reaction

Ishihara, Kazuaki,Hiraiwa, Yukihiro,Yamamoto, Hisashi

, p. 1564 - 1565 (2007/10/03)

The Me3SiX-induced Mukaiyama aldol reaction proceeds through each catalytic cycle under the influence of X-: the silyl group of Me3SiNTf2 does not release from -NTf2 and that of silyl enol ether intermolecularly transfers to the product, while the silyl group of Me3SiOTf remains in the product and that of the silyl enol ether becomes the catalyst for the next catalytic cycle.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 340165-30-2